Details of the Drug

General Information of Drug (ID: DMELU8J)

Drug Name
KB109
Indication
Disease Entry ICD 11 Status REF
Coronavirus Disease 2019 (COVID-19) 1D6Y Clinical Trial [1]
Cross-matching ID
TTD ID
DF8M3V

References

1 Clinical pipeline report, company report or official report of Kaleido Biosciences.